These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1520959)

  • 41. Antifungal potential of disulfiram.
    Khan S; Singhal S; Mathur T; Upadhyay DJ; Rattan A
    Nihon Ishinkin Gakkai Zasshi; 2007; 48(3):109-13. PubMed ID: 17667894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antifungal drug susceptibility testing. Working Party of the British Society for Antimicrobial chemotherapy.
    Rogers TR; Barnes RA; Denning DW; Evans EG; Hay RJ; Prentice AG; Speller DC; Warnock DW; Warren RE
    J Antimicrob Chemother; 1995 Dec; 36(6):899-909. PubMed ID: 8821590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of 5-hydroxytryptamine (serotonin) against Aspergillus spp. in vitro.
    Perkhofer S; Niederegger H; Blum G; Burgstaller W; Ledochowski M; Dierich MP; Lass-Flörl C
    Int J Antimicrob Agents; 2007 Apr; 29(4):424-9. PubMed ID: 17276041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutational resistance to fungitoxic benzimidazole derivatives in Aspergillus nidulans.
    Hastie AC; Georgopoulos SG
    J Gen Microbiol; 1971 Aug; 67(3):371-3. PubMed ID: 5137679
    [No Abstract]   [Full Text] [Related]  

  • 45. Sensitivity of Rhizobium species to certain fungicides.
    Afifi NM; Moharram AA; Hamdi YA; Abd-el-Malek Y
    Arch Mikrobiol; 1969; 66(2):121-8. PubMed ID: 5384629
    [No Abstract]   [Full Text] [Related]  

  • 46. The use of some disinfectants as fungicides.
    el-Bahay GM; Elmossalami E; Refai M
    Mykosen; 1968 Nov; 11(11):807-10. PubMed ID: 5758281
    [No Abstract]   [Full Text] [Related]  

  • 47. Salinity optima as affected by temperature for some "Usar" soil Aspergilli.
    Rai JN; Agarwal SC
    Mycopathol Mycol Appl; 1973 Aug; 50(4):307-12. PubMed ID: 4748982
    [No Abstract]   [Full Text] [Related]  

  • 48. Heterokaryon incompatibility in imperfect species of Aspergillus.
    Caten CE
    Heredity (Edinb); 1971 Apr; 26(2):299-312. PubMed ID: 5286388
    [No Abstract]   [Full Text] [Related]  

  • 49. Erratum to: Antifungal susceptibility profile of cryptic species of Aspergillus.
    Alastruey-Izquierdo A; Alcazar-Fuoli L; Cuenca-Estrella M
    Mycopathologia; 2015 Apr; 179(3-4):333-4. PubMed ID: 25487976
    [No Abstract]   [Full Text] [Related]  

  • 50. Occurrence of itraconazole-tolerant micromycetes in the soil and food products.
    Piecková E; Jesenská Z
    Folia Microbiol (Praha); 1999; 44(6):677-82. PubMed ID: 11097027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro activity of antifungal agents against clinical isolates of aspergilli.
    Otcenásek M
    Zentralbl Bakteriol; 1992 Jun; 277(1):100-5. PubMed ID: 1520959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro susceptibility of Aspergillus spp. clinical isolates to albendazole.
    Berthet N; Faure O; Bakri A; Ambroise-Thomas P; Grillot R; Brugère JF
    J Antimicrob Chemother; 2003 Jun; 51(6):1419-22. PubMed ID: 12716778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The in vitro susceptibility of some mycotic agents to a new orally active triazole, itraconazole.
    Otcenásek M
    J Hyg Epidemiol Microbiol Immunol; 1990; 34(2):129-34. PubMed ID: 2170505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Activity of itraconazole against clinical isolates of Aspergillus spp. and Fusarium spp. determined by the M38-P NCCLS method].
    Carrillo-Muñoz AJ; Quindós G; Ruesga M; Brió S; del Valle O; Rodríguez V; Hernández-Molina JM; Cantón E; Pemán J; Santos P
    Rev Esp Quimioter; 2001 Sep; 14(3):281-5. PubMed ID: 11753450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro susceptibility testing in Aspergillus species: an update.
    Lass-Flörl C
    Future Microbiol; 2010 May; 5(5):789-99. PubMed ID: 20441550
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.